Dapagliflozin suppresses vascular smooth muscle cell senescence by promoting autophagy

Back

ESC2025 Premium Access

Dapagliflozin suppresses vascular smooth muscle cell senescence by promoting autophagy

Session: Molecular drivers of vascular remodelling: from atherosclerosis to aneurysm therapy

Topic: Leukocytes, Inflammation, Immunity

Speaker: Doctor H. Yang (Changsha, CN)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Hui Yang

The Second Xiangya Hospital of Central South University, Changsha (China)

0 follower

7 more presentations in this session

PI3Ka protects against arteriosclerosis progression and plaque instability by controlling vascular smooth muscle cell functions

Speaker: Doctor M. Zierden (Cologne, DE)

VasCraft: new decellularized and re-endothelialized human vascular graft produced by tissue engineering for use in arterial bypass

Speaker: Mrs G. Iraola Picornell (Barcelona, ES)

Evidence from normal human arteries: IRF7 triggers atherosclerosis by enhancing vascular smooth muscle cells inflammation

Speaker: Doctor S. Cheng (Nanjing, CN)

Mass spectrometry-based proteomics identifies high glucose-induced changes in vascular smooth muscle (VSMCs) and sustained extracellular signal-regulated kinases (ERK) activation

Speaker: Mrs R. Aldahhasi (Leicester, GB)

MicroRNA-31-5p promotes vascular remodeling by modulating smooth muscle cell activity via STK40

Speaker: Doctor K. Kalies (Halle, DE)

Access the full session

Molecular drivers of vascular remodelling: from atherosclerosis to aneurysm therapy

Speakers: Doctor H. Yang, Doctor M. Zierden, Mrs G. Iraola Picornell, Doctor S. Cheng, Mrs R. Aldahhasi...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources